Abstract:Background/Aims: TNF-α receptor-associated factor (TRAF)-interacting protein with a forkhead-associated (FHA) domain (TIFA) may mediate the impact of TRAF on the development of lung cancer. The current study was conducted to investigate the expression of TIFA in lung adenocarcinoma and its potential role in the regulation of cancer cell proliferation and migration, and its influence on patient survival. Methods: Specimens of lung adenocarcinoma tissues and their adjacent normal lung tissues were obtained from 116 patients who underwent surgical resection of lung cancer. The expression of TIFA in the lung tissues was examined by immunohistochemistry, immunoblotting, and real-time RT-PCR in four different lung cancer cell lines and one normal bronchial epithelial cell line (BEAS-2B). TIFA was silenced by RNAi technique, and cell proliferation was then assessed by the CCK8 method. Furthermore, cell migration was determined by wound-healing trans-well and wound-healing migration assays. Additionally, cell-cycle arrest and apoptosis were assessed by flow cytometry analysis. Results: TIFA was positively detected in 63 (54.3%) out of 116 lung adenocarcinoma specimens, which was significantly higher than the respective rate established in normal tissues adjacent to the tumor (30.1%, p < 0.05). The overall survival rate was significantly lower in the patients with positive TIFA expression than that in the patients with negative TIFA expression (p < 0.05). TIFA was also highly expressed in the lung cancer cell lines (H1299, H1975, and HCC827) tested. It is noteworthy that siRNA suppressed the expression of TIFA, which contributed to the attenuation of cell proliferation and migration, but promoted cell-cycle arrest and apoptosis. Furthermore, the silencing of TIFA caused upregulation of p53, p21, and cleaved-caspase-3, but downregulation of Bcl-2, cyclin D1, and CDK4, as well as phosphorylation of IKKß, IκB, and p65. Conclusions: TIFA may serve as a biomarker in the prediction of lung adenocarcinoma. Furthermore, TIFA may modulate lung cancer cell survival and proliferation through regulating the synthesis of apoptosis-associated proteins.

TNF Receptor-Associated Factor 1 As a Biomarker for Assessment of Non-Small Cell Lung Cancer Metastasis and Overall Survival

TRAF1 is Critical for Regulating the BRAF/MEK/ERK Pathway in Non-Small Cell Lung Carcinogenesis.

Expression of Telomeric Repeat Binding Factor 1 in Non-Small Cell Lung Cancer.

Abnormal Expression and Clinical Significance of Telomeric Repeat Binding Factor 1 and Tankyrase 1 in Non-small Cell Lung Cancer

Expression of tumor necrosis factor receptor-associated factor 6 in lung cancer tissues.

High Expression Of Tumor Necrosis Factor Receptor-Associated Factor 2 Promotes Tumor Metastasis And Is Associated With Unfavorable Prognosis In Gastric Cancer

Down-regulation of tissue factor inhibits invasion and metastasis of non-small cell lung cancer.

The Roles and Mechanisms of TRAT1 in the Progression of Non-Small Cell Lung Cancer

Expression of Tumor Necrosis Factor Receptor 2 in Human Non-Small Cell Lung Cancer and Its Role As a Potential Prognostic Biomarker

TIFA Promotes Cell Survival and Migration in Lung Adenocarcinoma

Correlation of Increased Soluble Tumor Necrosis Factor Receptor 1 with Mortality and Dependence on Treatment in Non-Small-Cell Lung Cancer Patients: A Longitudinal Cohort Study

TNF-Alpha Pathway Alternation Predicts Survival of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer

Cancer marker TNFRSF1A: From single‑cell heterogeneity of renal cell carcinoma to functional validation

miR-146a-5p Plays an Oncogenic Role in NSCLC via Suppression of TRAF6

Variance of TNFAIP8 expression between tumor tissues and tumor-infiltrating CD4+ and CD8+ T cells in non-small cell lung cancer

TLR5: A Prognostic and Monitoring Indicator for Triple-Negative Breast Cancer

A comprehensive meta-analysis of tissue resident memory T cells and their roles in shaping immune microenvironment and patient prognosis in non-small cell lung cancer

Prognostic Significance of TAZ Expression in Resected Non-Small Cell Lung Cancer

Increased Expression of Mitochondrial Transcription Factor A and Nuclear Respiratory Factor-1 Predicts a Poor Clinical Outcome of Breast Cancer

Downregulation of TFAM inhibits the tumorigenesis of non-small cell lung cancer by activating ROS-mediated JNK/p38MAPK signaling and reducing cellular bioenergetics.

TBL1XR1 Predicts Isolated Tumor Cells and Micrometastasis in Patients with TNM Stage I/II Colorectal Cancer